Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
1,718,791
-
Share change
-
+548,564
-
Total reported value
-
$290,425,362
-
Price per share
-
$168.77
-
Number of holders
-
182
-
Value change
-
+$92,863,236
-
Number of buys
-
80
-
Number of sells
-
51
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q4 2025
As of 31 Dec 2025,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
182 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,718,791 shares.
The largest 10 holders included
McElhenny Sheffield Capital Management, LLC, ALBION FINANCIAL GROUP /UT, Generali Investments CEE, investicni spolecnost, a.s., APPLETON PARTNERS INC/MA, Apella Capital, LLC, NTV Asset Management LLC, Accurate Wealth Management, LLC, Allspring Global Investments Holdings, LLC, Ocean Park Asset Management, LLC, and FORBES J M & CO LLP.
This page lists
182
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.